Kolon Life Science Inc. (KOSDAQ:102940)
South Korea
· Delayed Price · Currency is KRW 30,800
-1,200 (-3.75%)
Jun 13, 2025, 3:30 PM KST
Kolon Life Science Revenue
Kolon Life Science had revenue of 44.83B KRW in the quarter ending March 31, 2025, with 16.27% growth. This brings the company's revenue in the last twelve months to 167.66B, up 27.19% year-over-year. In the year 2024, Kolon Life Science had annual revenue of 161.39B with 29.48% growth.
Revenue (ttm)
167.66B
Revenue Growth
+27.19%
P/S Ratio
2.28
Revenue / Employee
393.57M
Employees
426
Market Cap
382.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 161.39B | 36.75B | 29.48% |
| Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
| Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
| Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
| Dec 31, 2020 | 129.41B | -19.13B | -12.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| Kia Corporation | 109.25T |
| KB Financial Group | 14.93T |